SCHEMBL6076099

SCHEMBL6076099

O=C(O)C(=O)CC1(c2cccc3c2OCO3)CC1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
MGAM O43451 1/20 0.37
AMY1A P0DUB6 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
FAAH O00519 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAOB P27338 2/20 0.36
POLB P06746 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
MEN1 O00255 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6076287 0.95 ALDH1A1 (0.37) ALDH1A1CYP1A2CYP3A4CYP2C19KDM4C
SCHEMBL6077265 0.82 MGAM (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19MGAM
SCHEMBL6076448 0.71 MGAM (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19MGAM
SCHEMBL3924576 0.70 HDAC4 (0.44) ALDH1A1
SCHEMBL6076962 0.67 GSK3B (0.42) ALDH1A1KDM4CMGAMAMY1AGAA
SCHEMBL5079254 0.67 HDAC4 (0.39) KDM4EMEN1KMT2ANPSR1
SCHEMBL6583082 0.67 MAOA (0.50) ALDH1A1CYP3A4CYP2C19SMN1; SMN2MAOB
SCHEMBL4622614 0.67 MAOB (0.41) ALDH1A1CYP1A2CYP3A4CYP2C19KDM4C
SCHEMBL3402977 0.66 KDM4C (0.50) ALDH1A1KDM4CFAAHSMN1; SMN2POLB
SCHEMBL3534122 0.66 ALDH1A1 (0.39) ALDH1A1POLBKDM4EMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7112584-B2 Nonsteroidal antiinflammatory agents SCHERING AG (DE) 2006-09-26 US disclosed
EP-1572671-A1 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS Schering Aktiengesellschaft (DE) 2005-09-14 EP disclosed
US-20040209875-A1 Nonsteroidal antiinflammatory agents SCHERIN AKTIENGESELLSCHAFT (DE) 2004-10-21 US disclosed
WO-2004058733-A1 NON-STEROIDAL ANTI-INFLAMMATORY AGENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040209875-A1 Nonsteroidal antiinflammatory agents PTGS1, PTGER1, PTGES ALDH1A1 96/4885CYP1A2 101/4885CYP3A4 428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.